HSIC Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$89.31median target· current $85.75 (+4.2%)16 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
40 articles · sorted by datePage 1 of 2 · 40 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio25.91Forward 16.03
EPS (TTM)$3.314.5% YoY
Profit margin2.9%HEALTHCARE
Market cap$9.77BMid cap
Valuation
- Forward P/E
- 16.03
- PEG ratio
- 1.84
- P/B
- 2.99
- P/S (TTM)
- 0.73
- EV/EBITDA
- 13.64
Profitability & growth
- ROE (TTM)
- 8.8%
- Operating margin
- 5.9%
- Revenue growth YoY
- 6.3%
- Dividend yield
- —
- Beta
- 0.81
Last earnings
May 5, 2026 · Estimate $1.22 · Reported $1.32
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Henry Schein Inc
Company profileHenry Schein, Inc. is an American distributor of health care products and services with a presence in 32 countries.
Classification
- Sector
- Healthcare
- Industry
- Medical Distribution
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 135 DURYEA ROAD, MELVILLE, NY
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$9.77B
Shares outstanding$113.9M
52W high$89.34
52W low$61.95
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent